Innovative Health Iniciative (IHI) call 7 2023 (single-stage): Short pre-announcement on future opportunities


Convocatoria "cerrada"
Me interesa
Entidad convocante:
Innovative Health Initiative
Categoría:
Projectes de recerca
Ámbito:
Inicio:
Plazo interno:
Plazo real:
Descripción:

IHI calls for proposals (previously known as IMI calls) represent an opportunity for organisations involved in health research and healthcare to form consortia and apply to be part of cross-sector partnerships that bring together a range of stakeholders to tackle some of the biggest challenges in health research today.

The IHI call 7, which is a single-stage call, covering the following three topics:

  • Topic 1: Improving clinical management of heart disease from early detection to treatment.

Applicant consortia will be competing for the maximum financial contribution from IHI JU of up to EUR 25 000 000. NB: this amount is indicative and subject to change, pending approval by the IHI Governing Board. IHI JU estimates that an IHI JU financial contribution of EUR 12 500 000 would allow a proposal to address these outcomes appropriately. NB: this amount is indicative and subject to change, pending approval by the IHI Governing Board. Nonetheless, this does not preclude submission and selection of a proposal requesting different amounts.

  • Topic 2: User-centric technologies and optimised hospital workflows for a sustainable healthcare workforce.

Applicant consortia will be competing for the maximum financial contribution from IHI JU of up to EUR 25 000 000. NB: this amount is indicative and subject to change, pending approval by the IHI Governing Board. IHI JU estimates that an IHI JU financial contribution of EUR 12 500 000 would allow a proposal to address these outcomes appropriately. NB: this amount is indicative and subject to change, pending approval by the IHI Governing Board. Nonetheless, this does not preclude submission and selection of a proposal requesting different amounts.

  • Topic 3: Clinical validation of biomarkers for diagnosis, monitoring disease progression and treatment response.

Applicant consortia will be competing for the maximum financial contribution from IHI up to EUR 45 000 000. NB: this amount is indicative and subject to change, pending approval by the IHI Governing Board. IHI estimates that an IHI financial contribution of EUR 15 000 000 would allow a proposal to address these outcomes appropriately. NB: this amount is indicative and subject to change, pending approval by the IHI Governing Board. Nonetheless, this does not preclude submission and selection of a proposal requesting different amounts.

The topics are currently under consultation with the States' Representatives Group (SRG) and the Science and Innovation Panel (SIP). They may therefore change considerably between the versions published here and the call launch, and applicants should check the final, approved topic texts once the calls are launched.

All information regarding future IHI call topics is indicative and subject to change. Final information about future IHI calls will be communicated after approval by the IHI Governing Board.

Requisitos

To be defined in the final announcement of the call.

Splicitud

In case of interest, please click on "m'interessa" and we will contact you.